Immunocore Holdings
Stock Forecast, Prediction & Price Target
Immunocore Holdings (IMCR) stock Price Target by analysts
$24
Potential downside: -25.78%
Immunocore Holdings price prediction
What is Immunocore Holdings stock analysts` prediction?
Immunocore Holdings stock forecast: Based on 1 Wall Street analysts` predicted price targets for Immunocore Holdings in the last 3 months, the avarage price target is $24, with a high forecast of $NaN. The average price target represents a -25.78% change from the last price of $32.34.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Immunocore Holdings stock Price Target by analysts
Full breakdown of analysts given Immunocore Holdings price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
David Dai UBS | 0% 0/1 | 11 months ago | $24 -25.78% downside | $32.02 | StreetInsider | Previous targets (0) |
Justin Kim Oppenheimer | 0% 0/1 | about 1 year ago | $89 175.20% upside | $33.05 | StreetInsider | Previous targets (0) |
Graig Suvannavejh Mizuho Securities | 0% 0/2 | about 1 year ago | $72 122.63% upside | $33.44 | StreetInsider | Previous targets (1) |
Patrick Trucchio H.C. Wainwright | 0% 0/1 | about 1 year ago | $100 209.21% upside | $35.71 | StreetInsider | Previous targets (0) |
Peter Lawson Barclays | 0% 0/1 | about 1 year ago | $66 104.08% upside | $37.92 | TheFly | Previous targets (0) |
Graig Suvannavejh Mizuho Securities | 0% 0/2 | over 1 year ago | $88 172.10% upside | $57.25 | StreetInsider | Previous targets (1) |
Bill Maughan Canaccord Genuity | 0% 0/1 | over 1 year ago | $67 107.17% upside | $61.32 | StreetInsider | Previous targets (0) |
Rajan Sharma Goldman Sachs | 0% 0/1 | almost 3 years ago | $80 147.37% upside | $59.42 | TheFly | Previous targets (0) |
Michael Yee Jefferies | 100% 1/1 | about 3 years ago | $68 110.26% upside | $44.03 | TheFly | Previous targets (0) |
Immunocore Holdings Financial Estimates
Immunocore Holdings Revenue Estimates
Immunocore Holdings EBITDA Estimates
Immunocore Holdings Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $26.52M N/A | $143.73M 441.99% | $249.42M 73.53% | Avg: $331.81M Low: $302.25M High: $392.69M avg. 33.03% | Avg: $356.20M Low: $328.82M High: $407.90M avg. 7.35% | Avg: $454.89M Low: $419.92M High: $520.92M avg. 27.70% | Avg: $666.00M Low: $614.80M High: $762.66M avg. 46.40% |
Net Income
% change YoY
| $-131.52M N/A | $-41.22M 68.65% | $-55.28M -34.11% | Avg: $-121.79M Low: $-129.23M High: $-37.06M avg. -120.29% | Avg: $-135.60M Low: $-197.08M High: $1.54M avg. -11.34% | Avg: $-45.58M Low: $-54.18M High: $-41.02M avg. 66.38% | Avg: $76.62M Low: $68.96M High: $91.07M avg. 268.09% |
EBITDA
% change YoY
| $-135.11M N/A | $-36.45M 73.02% | $-51.64M -41.67% | Avg: $-226.15M Low: $-267.64M High: $-206.01M avg. -337.89% | Avg: $-242.78M Low: $-278.01M High: $-224.11M avg. -7.35% | Avg: $-310.04M Low: $-355.04M High: $-286.21M avg. -27.70% | Avg: $-453.92M Low: $-519.81M High: $-419.03M avg. -46.40% |
EPS
% change YoY
| -$3.1 N/A | -$0.9 70.96% | -$1.13 -25.55% | Avg: -$1.9 Low: -$2.64 High: -$0.76 avg. -68.51% | Avg: -$2.04 Low: -$4.03 High: $0.03 avg. -7.07% | Avg: -$0.93 Low: -$1.11 High: -$0.84 avg. 54.27% | Avg: $1.57 Low: $1.41 High: $1.86 avg. 268.09% |
Operating Expenses
% change YoY
| $161.68M N/A | $182.89M 13.11% | $308.04M 68.42% | Avg: $517.95M Low: $471.81M High: $612.97M avg. 68.14% | Avg: $556.02M Low: $513.28M High: $636.73M avg. 7.35% | Avg: $710.07M Low: $655.49M High: $813.14M avg. 27.70% | Avg: $1.03B Low: $959.68M High: $1.19B avg. 46.40% |
FAQ
What is Immunocore Holdings stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 50.71% in 2025-2028.
We have gathered data from 13 analysts. Their low estimate is -129.23M, average is -121.79M and high is -37.06M.
What is Immunocore Holdings stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 28.62% in 2025-2028.
We have gathered data from 13 analysts. Their low revenue estimate is $302.25M, average is $331.81M and high is $392.69M.
What is Immunocore Holdings stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 61.69% in 2025-2028.
We have gathered data from 13 analysts. Their low earnings per share estimate is -$2.64, average is -$1.9 and high is $-0.75.
What is the best performing analyst?
In the last twelve months 1 analysts have been covering Immunocore Holdings stock. The most successful analyst is David Dai.